149 related articles for article (PubMed ID: 37477388)
1. Analysis of lncRNAs profiles associated with ferroptosis can predict prognosis and immune landscape and drug sensitivity in patients with clear cell renal cell carcinoma.
Zong H; Li A; Huang Y; Che X; Zhang Y; Ma G; Zhou Z
J Biochem Mol Toxicol; 2023 Nov; 37(11):e23464. PubMed ID: 37477388
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma.
Ju L; Shi Y; Liu G
PeerJ; 2022; 10():e14506. PubMed ID: 36570012
[TBL] [Abstract][Full Text] [Related]
3. Construction of a ferroptosis-related signature based on seven lncRNAs for prognosis and immune landscape in clear cell renal cell carcinoma.
Wei SY; Feng B; Bi M; Guo HY; Ning SW; Cui R
BMC Med Genomics; 2022 Dec; 15(1):263. PubMed ID: 36528763
[TBL] [Abstract][Full Text] [Related]
4. Ferroptosis-Related Long Noncoding RNA Signature Predicts Prognosis of Clear Cell Renal Carcinoma.
Liu JW; Supandi F; Dhillon SK
Folia Biol (Praha); 2022; 68(1):1-15. PubMed ID: 36201853
[TBL] [Abstract][Full Text] [Related]
5. Ferroptosis-associated lncRNA prognostic signature predicts prognosis and immune response in clear cell renal cell carcinoma.
Lai J; Miao S; Ran L
Sci Rep; 2023 Feb; 13(1):2114. PubMed ID: 36747047
[TBL] [Abstract][Full Text] [Related]
6. Accurate prognostic prediction for patients with clear cell renal cell carcinoma using a ferroptosis-related long non-coding RNA risk model.
Xiang X; Guo Y; Chen Z; Zhang F; Qin Y
Cancer Biomark; 2023; 37(2):95-107. PubMed ID: 37248883
[TBL] [Abstract][Full Text] [Related]
7. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
[TBL] [Abstract][Full Text] [Related]
8. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
[TBL] [Abstract][Full Text] [Related]
9. Identification and Validation of a Ferroptosis-Related Long Non-Coding RNA (FRlncRNA) Signature to Predict Survival Outcomes and the Immune Microenvironment in Patients With Clear Cell Renal Cell Carcinoma.
Zhou Z; Yang Z; Cui Y; Lu S; Huang Y; Che X; Yang L; Zhang Y
Front Genet; 2022; 13():787884. PubMed ID: 35350243
[No Abstract] [Full Text] [Related]
10. Development of a novel disulfidptosis-related lncRNA signature for prognostic and immune response prediction in clear cell renal cell carcinoma.
Wang N; Hu Y; Wang S; Xu Q; Jiao X; Wang Y; Yan L; Cao H; Shao F
Sci Rep; 2024 Jan; 14(1):624. PubMed ID: 38182642
[TBL] [Abstract][Full Text] [Related]
11. Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma.
Sun JX; Xia QD; Liu CQ; Xu JZ; Xun Y; Lu JL; Hu J; Wang SG
Dis Markers; 2021; 2021():8800358. PubMed ID: 34512816
[TBL] [Abstract][Full Text] [Related]
12. Construction and validation of a ferroptosis-related long noncoding RNA signature in clear cell renal cell carcinoma.
Zhu Z; Zhang C; Qian J; Feng N; Zhu W; Wang Y; Gong Y; Li X; Lin J; Zhou L
Cancer Cell Int; 2022 Sep; 22(1):283. PubMed ID: 36104748
[TBL] [Abstract][Full Text] [Related]
13. A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma.
Hong Y; Lin M; Ou D; Huang Z; Shen P
BMC Cancer; 2021 Jul; 21(1):831. PubMed ID: 34281531
[TBL] [Abstract][Full Text] [Related]
14. Solute carrier-related signature for assessing prognosis and immunity in patients with clear-cell renal cell carcinoma.
Bao W; Han Q; Guan X; Wang Z; Gu M
Oncol Res; 2023; 31(2):181-192. PubMed ID: 37304236
[TBL] [Abstract][Full Text] [Related]
15. Integrated analysis on the N6-methyladenosine-related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma.
Qiu Y; Wang X; Fan Z; Zhan S; Jiang X; Huang J
Immun Inflamm Dis; 2021 Dec; 9(4):1596-1612. PubMed ID: 34432955
[TBL] [Abstract][Full Text] [Related]
16. A novel ferroptosis-related gene signature associated with cell cycle for prognosis prediction in patients with clear cell renal cell carcinoma.
Chen S; Zhang E; Guo T; Shao J; Wang T; Zhang N; Wang X; Zheng J
BMC Cancer; 2022 Jan; 22(1):1. PubMed ID: 34979993
[TBL] [Abstract][Full Text] [Related]
17. Construction of A Novel Ferroptosis-related Prognostic Risk Signature for Survival Prediction in Clear Cell Renal Cell Carcinoma Patients.
Tang F; Zhang J; Zhu L; Lai Y; Li Z; Lu Z; Tang Z; Mai Y; Huang R; He Z
Urol J; 2022 May; 19(4):289-299. PubMed ID: 35598038
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of m6A-associated ferroptosis genes in renal clear cell carcinoma.
Pang S; Zhao S; Dongye Y; Fan Y; Liu J
Cell Biol Int; 2024 Jun; 48(6):777-794. PubMed ID: 38440906
[TBL] [Abstract][Full Text] [Related]
19. Stemness related lncRNAs signature for the prognosis and tumor immune microenvironment of ccRCC patients.
Zhang M; Zhang J; Liang X; Zhang M
BMC Med Genomics; 2024 May; 17(1):150. PubMed ID: 38822402
[TBL] [Abstract][Full Text] [Related]
20. Single-Cell RNA-Seq Analysis Reveals Ferroptosis in the Tumor Microenvironment of Clear Cell Renal Cell Carcinoma.
Zhang J; Deng Y; Zhang H; Zhang Z; Jin X; Xuan Y; Zhang Z; Ma X
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]